Alerts will be sent to your verified email
Verify Email
MANKIND
|
Mankind Pharma
|
Zydus Lifesciences
|
Lupin
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceutical Sector
|
|||
|
Number of ANDA's Filed in USA
|
60.0 . | 486.0 . | 441.0 . |
|
Number of ANDA's Approved By USFDA
|
44.0 . | 421.0 . | 340.0 . |
|
Domestic Sales Growth - YoY
|
n/a | 8.4 % | 8.0 % |
|
R&D as a % of Total Sales
|
2.15 % | 8.1 % | 9.6 % |
|
Unclassified
|
|||
|
Advertisement Spend as a % of Total Sales
|
5.84 % | n/a | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
23.46 % | 16.96 % | 2.19 % |
|
5yr average Equity Multiplier
|
1.37 | 1.66 | 1.79 |
|
5yr Average Asset Turnover Ratio
|
0.95 | 0.65 | 0.72 |
|
5yr Avg Net Profit Margin
|
17.9 % | 16.78 % | 1.82 % |
|
Price to Book
|
6.78 | 4.02 | 5.19 |
|
P/E
|
48.8 | 21.3 | 27.19 |
|
5yr Avg Cash Conversion Cycle
|
-44.05 Days | -68.16 Days | -70.43 Days |
|
Inventory Days
|
58.78 Days | 44.51 Days | 51.95 Days |
|
Days Receivable
|
24.18 Days | 46.37 Days | 52.75 Days |
|
Days Payable
|
130.75 Days | 164.0 Days | 155.88 Days |
|
5yr Average Interest Coverage Ratio
|
56.97 | 24.75 | 3.96 |
|
5yr Avg ROCE
|
30.07 % | 17.68 % | 8.04 % |
|
5yr Avg Operating Profit Margin
|
24.6 % | 22.37 % | 12.57 % |
|
5 yr average Debt to Equity
|
0.05 | 0.3 | 0.34 |
|
5yr CAGR Net Profit
|
13.17 % | 26.82 % | n/a |
|
5yr Average Return on Assets
|
17.12 % | 10.66 % | 1.4 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
72.7 % | 74.99 % | 46.92 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-3.8 % | 0.11 % | 0.14 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
5.84 % | 0.81 % | 1.83 % |
|
Mankind Pharma
|
Zydus Lifesciences
|
Lupin
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Acute vs Chronic
|
Acute vs Chronic
|
-
|
Acute vs Chronic
|
|
Brand Wise Break-Up
|
Brand Wise Break-Up
|
-
|
-
|